NOI-NHLBI Animal Facility Containment Cubicle System Upgrade
Archived on October 1, 2026. Original response deadline: . Full description on SAM.gov.
Overview
- Response deadline
- 3:00 PM EDT
- Posted
- September 14, 2026
- Notice type
- Special Notice
- Set-aside
- No Set aside used
- NAICS
- 339113: Surgical Appliance and Supplies Manufacturing
- Agency
- Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH
Notice details
- Place of performance
- Bethesda, Maryland, 20892
- Last updated
- Oct 28, 2026
- First published
- Last updated on SAM.gov
Identifiers
- Solicitation number
- PCA-NHLBI-07677
- Notice ID
- 9e70c21b1b784cb780e5d2d6c6bd6e65
Description
NOTICE OF INTENT TO SOLE SOURCE
Notice Type: Special Notice / Intent to Sole Source
Title: NHLBI Animal Facility Containment Cubicle System Upgrade
Agency: National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI)
Reference/Solicitation No.: PCA-NHLBI-07677
NAICS Code: 339113 – Surgical Appliance and Supplies Manufacturing
Point of Contact: Travis Brown, travis.brown@nih.gov
Description:
The National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI), intends to negotiate and award a firm-fixed-price purchase order on a sole-source basis to BH, Inc. dba Britz & Company (a Tecniplast company), Sheridan, WY, under the authority of FAR 13.106-1(b), Soliciting from a single source.
The requirement is to upgrade the existing biocontainment cubicle system within the NHLBI Central Animal Facility. The animal facility supports research using animal models, including studies involving biohazardous and chemical agents that require specialized containment. The existing containment cubicle system has been in continuous operation for more than 20 years and has reached the end of its service life, resulting in increased repair costs, limited parts availability, and elevated operational risk.
The scope of the requirement includes, at a minimum:
- Upgrade of the existing containment cubicle system (approximately three upgrade kits) to restore full containment functionality and safety compliance;
- Demolition and removal of the existing telescoping cubicle doors and columns;
- Installation, setup, assembly, startup, and training; and
- Associated shipping, handling, and freight to the facility in Bethesda, MD.
The upgraded system must integrate with the facility's existing containment infrastructure, including the current spatial footprint, structural configuration, and specialized airflow/containment systems, without requiring architectural modification to the dedicated containment rooms, and must maintain compatibility with the facility's existing animal housing racks and biosafety requirements.
Statement of Intent:
This notice is NOT a request for competitive proposals or quotations, and no solicitation document is available. The Government intends to award to the source identified above. However, the Government will consider capability statements from any responsible source that believes it can meet the requirement described above.
Interested firms must submit a written capability statement demonstrating, with specificity, their ability to meet the stated technical, integration, spatial, and safety requirements—including the ability to deliver an upgraded solution that integrates with the existing containment infrastructure without architectural modification and maintains compatibility with existing housing racks and biosafety requirements. Statements of interest that do not clearly demonstrate the ability to meet these requirements will not be considered a basis for competition.
A determination by the Government not to compete this action based on responses to this notice is solely within the discretion of the Government.
Response Due Date: Capability statements must be received no later than 3:00 PM ET on September 16, 2026. Responses submitted after this date and time may not be considered.
Submission Instructions: Submit responses via email to Travis Brown at travis.brown@nih.gov, referencing PCA-NHLBI-07677 in the subject line.
Award Overview
No prior contract identified
No prior award matched this notice's agency, NAICS, place of performance and PSC within 18 months. It may be a new requirement.
Contacts
Contracting Officer
Primary Contact
Documents
No documents available.
Lifecycle
- 1Version 1Special NoticeArchived
NHLBI Animal Facility Containment Cubicle System Upgrade
- 3Version 3Special NoticeArchivedCurrent
NOI-NHLBI Animal Facility Containment Cubicle System Upgrade
Similar Opportunities
Title | Match | Phase | Deadline |
|---|---|---|---|
The Indian Health Service (IHS) intends to procure DataRay D4™ (DataRay platform, fourth‑generation release) to support the Northern Navajo Medical Center (NNMC). See attached documentation | - | Market Research | 11/13/2026 |
This acquisition is for three (3) Philips Cardiac Workstation 7000 units, compatible trolleys, and implementation services for patient care at the National Institutes of Health (NIH) Clinical Center (CC) Department of Clinical Research Informatics (DCRI). • Product Service Code: 6515 – Medical Instruments, Equipment, and Supplies • NAICS Code: 339112 – Surgical and Medical Instrument Manufacturing • Place of Performance: Bethesda, MD 20892 USA POTS: 27-000177 Description: This is a notice of intent, not a request for a quotation. A solicitation document will not be issued and quotations will not be requested. The National Institutes of Health (NIH) intends to award a fixed price purchase order to Philips North America, located at 222 Jacobs St, East Cambridge, MA, on a firm fixed price sole source award basis to provide three (3) Philips Cardiac Workstation 7000 units, compatible trolleys, and implementation services for patient care at the National Institutes of Health (NIH) Clinical Center (CC) Department of Clinical Research Informatics (DCRI). The Clinical Center’s requirement is driven by interoperability with its existing EKG-to-CRIS environment. The SOW states that the Philips model can be added to the existing CRIS interfaces, enabling electronic orders/results and an automated workflow in which authorized staff can review, annotate, and sign EKG reports online for automatic upload to CRIS. The SOW further states that this automation is intended to reduce errors, keep reports digital, improve availability, and improve patient safety. A different manufacturer’s product that requires development of an additional interface would not meet the requirement as presently defined because it would add interface development, validation, implementation, and operational risk outside the intended scope. Accordingly, the unique qualification is native/established compatibility with the existing Philips-to-CRIS interface and workflow, not merely the manufacturer’s trade name. This acquisition is being conducted using policies unique to the Federal Acquisition Regulation (FAR) Part 13 – Simplified Acquisition Procedures, Subpart 13.106-1(b)(1), For purchases not exceeding the simplified acquisition threshold (SAT), contracting officers may solicit from one source if the contracting officer determines that the circumstance of the contract action deem only one source reasonably available. Contracts awarded using FAR Part 13-Simplified Acquisition Procedures are exempt from the requirements of FAR Part 6-Competition Requirements. Interested parties may identify their interest and capabilities in response to this posting. The determination by the Government not to compete the proposed requirement based upon responses to this notice is solely within the discretion of the Government. Comments to this announcement, referencing this posting number, may be submitted to the NIH, Clinical Center, Office of Purchasing and Contracts, prior to the closing date specified in this announcement, to the attention of Kristin Nagashima, Contract Specialist via email to Kristin.nagashima@nih.gov by November 23rd, 2026 at 5pm EST. | - | Special Notice | 11/23/2026 |
This is a Notice of Intent, not a request for proposal. The National Institute of Health, Clinical Center (NIH-CC) intends to negotiate on an other than full and open competition basis with the following vendor: Bard Peripheral Vascular Inc. Acquisition Description: Procurement of BD Mission™ Disposable Core Biopsy Instrument (semi-automatic, single-use) for use in Interventional Radiology image-guided core needle biopsy procedures. Device is compatible with the BD TruGuide™ Disposable Coaxial Biopsy Needle and is available in 14G–20G gauges and 6–25 cm lengths to accommodate a range of lesion depths and target sites. Features include Advanced Echogenic Technology for enhanced ultrasound visibility, a Fire Ready Indicator, and a penetration depth indicator (10mm/20mm presets). Core Function: Supplies required: BD Mission™ Disposable Core Biopsy Instrument(s), single-use, sterile, for IR core needle biopsy procedures. Delivery is requested on an as-needed/recurring basis via standard vendor shipment The statutory authority for this sole source requirement is 41 U.S.C. 253(c) (1) as implemented by FAR 6.302-1 only one responsible source and no other supply of service will satisfy agency requirements. THIS IS NOT A REQUEST FOR PROPOSAL. All responsible sources that could provide the required may submit a capability statement that will be considered by email (subject line to reference NOI-OLAO-CC-27-000988) by 12:00 PM eastern standard time on 11/08/2026 to: valerie.gregorio@nih.gov. All responses received by the closing date of this synopsis will be considered by the Government. A determination not to compete this requirement, based upon responses to this notice, is solely within the discretion of the Government. | - | Pre-Solicitation | 11/08/2026 |
This acquisition is for renewal of the annual service contract for the SCIEX QTRAP 6500 mass spectrometer located in the Clinical Pharmacology Laboratory (CPL) at the National Institutes of Health (NIH). • Product Service Code: 6515 – Medical Instruments, Equipment, and Supplies • NAICS Code: 339112 – Surgical and Medical Instrument Manufacturing • Place of Performance: Bethesda, MD 20892 USA POTS: 27-000151 Description: This is a notice of intent, not a request for a quotation. A solicitation document will not be issued and quotations will not be requested. The National Institutes of Health (NIH) intends to award a fixed price purchase order to AB Sciex LLC, located at 1201 Radio Rd, Redwood City, CA 94065, on a firm fixed price sole source award basis to provide service to the Sciex QTRAP 6500 mass spectrometer at the NIH CPL. SCIEX is the original equipment manufacturer (OEM) of the QTRAP 6500 mass spectrometer. Only SCIEX-certified engineers can service internal components, ensure firmware compatibility, and maintain the instrument’s warranty. Third-party vendors do not have access to proprietary parts, software patches, or SCIEX OS upgrades, and cannot ensure 48-hour on-site response times. SCIEX’s FlexPlan is the only service contract that: • Guarantees coverage for software, firmware, and hardware • Preserves instrument warranty • Provides regulatory-grade validation support • Ensures minimal downtime with guaranteed two-business-day response • Offers discounts on future upgrades and validation services This acquisition is being conducted using policies unique to the Federal Acquisition Regulation (FAR) Part 13 – Simplified Acquisition Procedures, Subpart 13.106-1(b)(1), For purchases not exceeding the simplified acquisition threshold (SAT), contracting officers may solicit from one source if the contracting officer determines that the circumstance of the contract action deem only one source reasonably available. Contracts awarded using FAR Part 13-Simplified Acquisition Procedures are exempt from the requirements of FAR Part 6-Competition Requirements. Interested parties may identify their interest and capabilities in response to this posting. The determination by the Government not to compete the proposed requirement based upon responses to this notice is solely within the discretion of the Government. Comments to this announcement, referencing this posting number, may be submitted to the NIH, Clinical Center, Office of Purchasing and Contracts, prior to the closing date specified in this announcement, to the attention of Kristin Nagashima, Contract Specialist via email to Kristin.nagashima@nih.gov by November 5, 2026 at 5pm EST. | - | Special Notice | 11/05/2026 |
This is a Notice of Intent, not a request for proposal. The National Institute of Health, Clinical Center (NIH-CC) intends to negotiate on an other than full and open competition basis with the following vendor: Illumina, Inc. Acquisition Description: The purpose of this acquisition is to purchase two Illumina MiSeq i100 series instruments. These instruments will be used by the NIH HLA Laboratory to produce high resolution HLA typing results for the numerous transplant protocols supported by the laboratory. It will replace the current Illumina MiSeq instruments in the lab that were purchased in 2021 and 2022. The vendor will discontinue service on the current model of the MiSeq. New instruments are required to ensure time to validate these replacements before discontinuation of service. The total dollar value for this order is $139,100.52. The MiSeq is an integrated instrument that performs clonal amplification, genomic DNA sequencing, and data analysis with base calling, alignment, variant calling, and reporting in a single run. The MiSeq provides the Lab with the highest HLA typing results possible. The transplant protocols served by the HLA Lab require highest resolution possible to increase the chance of a successful transplant. The HLA Lab currently owns two MiSeq instruments, so the procedures and Quality Control assessments are in place. The order aims to replace the Illumina Miseq – s/n M07700 (property ID is 02223449) and s/n M08636 (property ID is 02268689) that were purchased in 2019 and 2022. Replacement is necessary to ensure proper performance of these instruments prior to discontinuation of service for the current model of the Illumina MiSeq instruments by the vendor. The statutory authority for this sole source requirement is 41 U.S.C. 253(c) (1) as implemented by FAR 6.302-1 only one responsible source and no other supply of service will satisfy agency requirements. THIS IS NOT A REQUEST FOR PROPOSAL. All responsible sources that could provide the required may submit a capability statement that will be considered by email (subject line to reference NOI-OLAO-CC-27-000836) by 12:00 PM eastern standard time on 11/27/2026 to: valerie.gregorio@nih.gov. All responses received by the closing date of this synopsis will be considered by the Government. A determination not to compete this requirement, based upon responses to this notice, is solely within the discretion of the Government. | - | Pre-Solicitation | 11/27/2026 |
Additional Details
Solicitation Number
PCA-NHLBI-07677
Archive Date
Oct 1, 2026
Office Address
Bethesda, MD, 20892, US